CHPF antibody (N-Term)

Catalog No. ABIN635153

The Rabbit Polyclonal anti-CHPF antibody has been validated for WB. It is suitable to detect CHPF in samples from Human.

Quick Overview for CHPF antibody (N-Term) (ABIN635153)

Target: CHPF (Chondroitin Polymerizing Factor (CHPF))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CHPF antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-CHPF Antibody

Binding Specificity: N-Term

Specificity: CHSY2 antibody was raised against the N terminal Of Chsy-2

Purification: Affinity purified

Immunogen: CHSY2 antibody was raised using the N terminal Of Chsy-2 corresponding to a region with amino acids PPLQQRRRGREPEGATGLPGAPAAEGEPEEEDGGAAGQRRDGRPGSSHNG

Application Details

Application Notes: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

CHSY2 Blocking Peptide, (ABIN5612880), is also available for use as a blocking control in assays to test for specificity of this CHSY2 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CHSY-2 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Target Details for CHPF

Target: CHPF (Chondroitin Polymerizing Factor (CHPF))

Alternative Name: CHSY2

Background: CHSY-2 has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. CHSY-2 transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Specific activity of CHSY-2 is much reduced compared to CHSY1.CSS3 is a glycosyltransferase that has both glucuronyltransferase and N-acetylgalactosaminyltransferase activities.

Molecular Weight: 100 kDa (MW of target protein)

Pathways: Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interactome